SummaryRMgm-235
|
Successful modification | The parasite was generated by the genetic modification |
The mutant contains the following genetic modification(s) | Gene disruption |
Reference (PubMed-PMID number) |
Reference 1 (PMID number) : 18389080 |
MR4 number | |
top of page | |
Parent parasite used to introduce the genetic modification | |
Rodent Malaria Parasite | P. berghei |
Parent strain/line | P. berghei ANKA |
Name parent line/clone | P. berghei ANKA cl15cy1 |
Other information parent line | |
top of page | |
The mutant parasite was generated by | |
Name PI/Researcher | T. Ono; A. Rodriguez |
Name Group/Department | Department of Medical Parasitology |
Name Institute | New York University School of Medicine |
City | New York |
Country | USA |
top of page | |
Name of the mutant parasite | |
RMgm number | RMgm-235 |
Principal name | acα- (C1 and C2) |
Alternative name | acα- |
Standardized name | |
Is the mutant parasite cloned after genetic modification | Yes |
top of page | |
Phenotype | |
Asexual blood stage | Not different from wild type |
Gametocyte/Gamete | Not different from wild type |
Fertilization and ookinete | Not different from wild type |
Oocyst | Not different from wild type |
Sporozoite | Normal numbers of salivary gland sporozoites are formed. Gliding motility of sporozoites was comparable to that of wild type parasites. The cell-traversal activity of mutant sporozoites was slightly lower, but not significantly different from wild type sporozoites. The mutant sporozoites are approximately 50% less infective to Hepa1-6 cells and to C57Bl6 mice than wild type sporozoites. |
Liver stage | Gliding motility of sporozoites was comparable to that of wild type parasites. The cell-traversal activity of mutant sporozoites was slightly lower, but not significantly different from wild type sporozoites. The mutant sporozoites are approximately 50% less infective to Hepa1-6 cells and to C57Bl6 mice than wild type sporozoites. |
Additional remarks phenotype | Mutant/mutation Biochemical analyses indicate that increases in cAMP levels in sporozoites mediate apical regulated exocytosis, which activates sporozoites for host cell invasion. By analysis of the mutant deficient in adenylyl cyclase α (ACα), evidence is presented that suggest that the cAMP signaling pathway is essential to induce apical exocytosis, which is activated during migration through cells. To confirm that the phenotype observed in the mutant PbACα- sporozoites is caused specifically by depletion of the Pbacα gene, one of the PbACα- lines was complemented with ACα using a DNA construct with the human (h) dhfr selectable marker and two fragments of 4.3kb (5′) and 0.5 kb (3′) of the ACα gene of P. berghei. The linearized vector integrates into the acα locus. Selection of transformed parasites was performed by treating infected animals with WR99210 (20 mg/kg bodyweight)]. One parasite clone (Cmp) in which the acα gene was integrated into the acα locus was selected for analysis. |
top of page | |||||||||||||||||||||||||
Details of the target gene | |||||||||||||||||||||||||
Gene Model of Rodent Parasite | PBANKA_1037500 | ||||||||||||||||||||||||
Gene Model P. falciparum ortholog | PF3D7_1411100 | ||||||||||||||||||||||||
Gene product | conserved Plasmodium membrane protein, unknown function | ||||||||||||||||||||||||
Gene product: Alternative name | Adenylyl cyclase α; ACα | ||||||||||||||||||||||||
top of page | |||||||||||||||||||||||||
Details of the genetic modification | |||||||||||||||||||||||||
Inducable system used | No | ||||||||||||||||||||||||
Additional remarks inducable system | |||||||||||||||||||||||||
Type of plasmid/construct used | Plasmid double cross-over | ||||||||||||||||||||||||
PlasmoGEM (Sanger) construct/vector used | No | ||||||||||||||||||||||||
Modified PlasmoGEM construct/vector used | No | ||||||||||||||||||||||||
Plasmid/construct map | |||||||||||||||||||||||||
Plasmid/construct sequence | |||||||||||||||||||||||||
Restriction sites to linearize plasmid | |||||||||||||||||||||||||
Partial or complete disruption of the gene | Partial | ||||||||||||||||||||||||
Additional remarks partial/complete disruption | It is thought that ACα presents a transmembrane K+-channel domain and an intracellular adenylyl cyclase (AC) domain, which are functionally linked. The disruption described here removes the AC domain but leaves part of the upstream sequence domain with high homology to K+-channel intact. | ||||||||||||||||||||||||
Selectable marker used to select the mutant parasite | tgdhfr | ||||||||||||||||||||||||
Promoter of the selectable marker | pbdhfr | ||||||||||||||||||||||||
Selection (positive) procedure | pyrimethamine | ||||||||||||||||||||||||
Selection (negative) procedure | No | ||||||||||||||||||||||||
Additional remarks genetic modification | |||||||||||||||||||||||||
Additional remarks selection procedure | |||||||||||||||||||||||||
Primer information: Primers used for amplification of the target sequences
Primer information: Primers used for amplification of the target sequences
| |||||||||||||||||||||||||
top of page |